Published in Hepatitis Weekly, May 20th, 1996
A study from Japan suggested that the branched DNA probe assay (bDNA) is a better predictor of a complete response to interferon than measurement by competitive reverse transcription polymerase chain reaction (cRT-PCR), although the bDNA probe assay is less sensitive than cRT-PCR for detecting HCV RNA at lower concentrations.
The efficacy of interferon-alpha (IFN-(alpha)) in the treatment of patients with chronic hepatitis C is not fully known, and several reports have found that...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly